CNTB logo

CNTB EBITDA

Annual EBITDA

-$58.37 M
+$58.37 M+50.00%

December 31, 2023


Summary


Performance

CNTB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTBprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CNTB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+50.0%--
3 y3 years+51.0%--
5 y5 years-143.4%--

CNTB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+71.0%
5 y5-year-143.4%+71.0%
alltimeall time-143.4%+71.0%

Connect Biopharma Holdings Limited EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-$58.37 M(-50.0%)
-
-
Dec 2022
-$116.74 M(-42.0%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
-$201.36 M(+69.1%)
-
-
Dec 2020
-$119.04 M(+396.4%)
-
-
Dec 2019
-$23.98 M
-
-

FAQ

  • What is Connect Biopharma Holdings Limited annual EBITDA?
  • What is the all time high annual EBITDA for Connect Biopharma Holdings Limited?
  • What is Connect Biopharma Holdings Limited annual EBITDA year-on-year change?

What is Connect Biopharma Holdings Limited annual EBITDA?

The current annual EBITDA of CNTB is -$58.37 M

What is the all time high annual EBITDA for Connect Biopharma Holdings Limited?

Connect Biopharma Holdings Limited all-time high annual EBITDA is -$23.98 M

What is Connect Biopharma Holdings Limited annual EBITDA year-on-year change?

Over the past year, CNTB annual EBITDA has changed by +$58.37 M (+50.00%)